Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Watertown, MA, US. The stock last traded at $80.05, up 1.53% on the session, giving a market capitalisation of $3.07B. On trailing twelve-month figures it carries a trailing P/E of -12.13, a net margin of 0.0%. Its beta of 2.06 implies it has historically moved more than the broad market.
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Disc Medicine, Inc. is most often compared with the following Healthcare names: